SCHEMBL10249846

SCHEMBL10249846

Cc1cccc(N(C(C)c2ccccc2F)S(=O)(=O)c2ccccc2C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.42
RECQL P46063 1/20 0.42
KAT6A Q92794 1/20 0.36
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
GLA P06280 3/20 0.35
HCRTR2 O43614 2/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
HTR1A P08908 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR7 P34969 1/20 0.34
DRD3 P35462 1/20 0.34
HTR6 P50406 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
IGLV6-57 P01721 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117856 0.93 RECQL (0.46) HSD11B1RECQLKAT6AGLAHCRTR2
SCHEMBL2120045 0.90 RECQL (0.40) HSD11B1RECQLTSHRMAPK1GLA
SCHEMBL2118908 0.90 TSHR (0.48) HSD11B1RECQLTSHRMAPK1GLA
SCHEMBL2119849 0.86 HSD11B1 (0.50) HSD11B1KAT6AHCRTR2
SCHEMBL2120059 0.78 PSEN1 (0.44) HSD11B1KAT6ATSHRMAPK1KMT2A
SCHEMBL3711033 0.73 PKM (0.47) HSD11B1RECQLTSHRMAPK1GLA
SCHEMBL2120075 0.70 PSEN1 (0.44) HSD11B1MAPK1KMT2AALDH1A1MAPT
SCHEMBL2117553 0.68 HSD11B1 (0.44) HSD11B1TSHRMAPK1HCRTR2MEN1
SCHEMBL3706061 0.62 PKM (0.50) HSD11B1RECQLTSHRMAPK1HCRTR2
SCHEMBL3822613 0.60 MCOLN3 (0.60) TSHRGLAPKMHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-19 US disclosed
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-19 US disclosed
WO-2010125831-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM5, TRPM6 HSD11B1 3399/4885RECQL 4671/4885KAT6A 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.